PharmaVoice 100: Page 2
-
The 2022 Red Jacket honorees
Our annual PharmaVoice 100 “hall of fame” winners raise the bar on transformative leadership in life sciences.
Sept. 15, 2022 -
Profile // Red Jacket honorees 2022
Red Jacket: Udit Batra
A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.”
By PharmaVoice staff • Sept. 15, 2022 -
Profile // Red Jacket honorees 2022
Red Jacket: Jim Lang
The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.
By PharmaVoice staff • Sept. 15, 2022 -
Profile
Red Jacket: Quita Highsmith
The VP and chief diversity officer of Genentech is driving enterprise-wide strategies to influence how the biotech giant approaches DE&I — from clinical trials to career advancement.
By PharmaVoice staff • Sept. 15, 2022 -
Profile // PharmaVoice 100
Disrupters: Jim Anthony
With a ready-for-anything attitude and a knack for relationship-building, the executive vice president and global head of Parexel Biotech is growing the CRO with a patient-first approach.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Renata Campos
Takeda's Growth and Emerging Markets Business Unit president is driving growth by doing what’s right for patients and her teams.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Lisa Walters-Hoffert
Daré Bioscience’s CFO and co-founder is determined to rapidly advance innovations in women’s health.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Armon Sharei
The CEO of SQZ Biotech is leveraging a technology platform that is simple in its design yet targeted at making cell therapy to break down barriers to the treatments.
By Michael Gibney • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Samantha Du
The CEO of Zai Lab is at the forefront of the movement to boost innovation in China’s biotech sector while delivering needed solutions to patients around the world.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Dr. Penelope Manasco
How the NIH-trained scientist and CEO of MANA RBM is charting a new way forward in conducting clinical trials.
By Alexandra Pecci • Sept. 6, 2022 -
Profile // PharmaVoice 100
Tech Wizards: Kunal Ghosh
The leader of Inscopix embodies a 'bootstrap' approach to entrepreneurship, from soldering early versions of the Inscopix technology to taking a 'science-first' approach to fundraising.
By Alexandra Pecci • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Adrelia Allen
Merck & Co.’s senior director of clinical trial patient diversity is transforming the pharma giant’s approach to inclusion and equality.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Tech Wizards: Dominique Demolle
How the CEO of Cognivia is revolutionizing drug development with psychonomics.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Trishna Bharadia
As a patient advocate, The Spark Global’s owner is transforming how pharma companies approach patient centricity.
By Alexandra Pecci • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Jeff Fischer
The co-founder and president led Longhorn Vaccines and Diagnostics to an unprecedented surge in production of its testing tech at the height of COVID-19 and is now pursuing a universal flu vaccine.
By Karissa Waddick • Sept. 6, 2022 -
Profile // PharmaVoice 100
Legacy Leaders: Dr. Henrietta Ukwu
Novavax’s regulatory head helped the company pull off its first approvals with the FDA and the EMA — but her accomplishments in pharma run deep.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Legacy Leaders: Nancy Lurker
The CEO of EyePoint Pharmaceuticals is positioning the company to fundamentally reshape how retinal diseases are treated.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Innovators: Karin Jooss
The EVP and head of R&D at Gritstone bio is using her decades as a visionary drug developer to help the company advance vaccines for cancer.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Charlene Stern
How the chief lawyer of Editas Medicine is using a multi-lens approach to bolster the development of game-changing genomic medicines.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Innovators: Shanthi Ganeshan
The longtime regulatory pro has used innovative strategies to deliver emerging oncology therapies to patients from her position as head of regulatory affairs at Stemline.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Dr. Mary-Ann Etiebet
Merck’s associate vice president of health equity is making DE&I a part of the pharma giant's day-to-day strategy.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Innovators: Johnna Wesley
The vice president of Type 1 diabetes and kidney disease research at Novo Nordisk is leading the charge to deliver paradigm-changing breakthroughs in the space.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Ben Yerxa
The CEO in retinal diseases sees opportunities for drug development success by merging the work of a gene therapy startup with venture philanthropy.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Samantha Singer
Abata’s CEO is stepping into the ring to fight for patients with progressive MS and other autoimmune disorders.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Faraz Ali
The CEO is leading Tenaya Therapeutics forward in ways that combine people-focused leadership, a strong dedication to patients and bold ideas for the future.
By Alexandra Pecci • Sept. 6, 2022